Page 118 - 2026 SMOG
P. 118

DOPAMINE (INTROPIN)
                              Class/Mechanism of Action
         •  Adrenergic Agonist; Inotrope; Vasopressor
           Stimulates adrenergic and dopaminergic receptors. Low doses are mainly dopaminergic-stimulating
           and produce renal and mesenteric vasodilation. High doses stimulate both dopaminergic and beta -
                                                                     1
           adrenergic receptors, producing cardiac stimulation and renal vasodilation. Large doses stimulate
           alpha-adrenergic receptors.
              ˚  Onset of action—Adults: within 5min; Duration—Adults: <10min
                                    Indications
         •  Labeled Indications
              ˚  Treatment of nonhemorrhagic shock (e.g., neurogenic, renal failure, cardiac decompensation)
             persisting after adequate fluid volume replacement (fluidrefractory shock)
         •  Off-Label Indications
              ˚  Symptomatic bradycardia or heart block unresponsive to atropine
                                  Contraindications
         •  Hypersensitivity to sulfites
         •  Ventricular Fibrillation
         •  Pheochromocytoma
         •  Uncorrected tachyarrhythmias
                            Adverse Reactions/Precautions
         •  No applicable use in hemorrhagic shock unless fluid replacement therapy is maximized!
           Maximize use of Blood products/Crystalloids before considering use in hemorrhagic shock.
         •  Doses >20mcg/kg/min likely do not have a beneficial effect on blood pressure and may increase the
           risk of tachyarrhythmias. Consider other agents when doses above this range are required.
         •  Vesicant (causes blisters): Avoid extravasation, as it will cause tissue damage/necrosis
         •  Assure adequate circulatory volume to minimize the need for vasoconstrictors. Monitor BP closely,
           avoid hypertension, and adjust infusion rate as needed.
         •  Not recommended for use in Septic Shock patients
         •  Pregnancy: Do not withhold in Cardiac patients.
         •  Lactation: Unknown
                                Dose/Administration
                                                     PEDIATRIC
                      ADULT
                                              (Always reference Broselow Tape)
         Hemodynamic Support             Hemodynamic Support
         •  IV                           •  IV
              ˚  0.5–20mcg/kg/min; lower doses are     ˚  2–20mcg/kg/min; titrate to desired response
             preferred; titrate to desired response
         Bradycardia/ROSC
         •  IV/IO
              ˚  5–20mcg/kg/min; titrate to desired response
         Note: Add an additional vasopressor if
         Dopamine doses of 20mcg/kg/min are inadequate
         (phenylephrine, norepinephrine, epinephrine)
         Note: Dopamine MOA/efficacy is dependent on
         the administered dose. For:
         •  Renal perfusion: 1–5mcg/kg/min
         •  Cardiac: 5–10mcg/kg/min
         •  Vasoconstriction: >10mcg/kg/min

        110  •   MEDICATIONS
   113   114   115   116   117   118   119   120   121   122   123